Regulation of aortic atrial natriuretic factor and angiotensinogen in experimental hypertension

Journal of Cardiovascular Pharmacology

Volumn 32, Issue 6, 1998, Pages 1001-1008

  Ogawa, Tsuneo ^a   Linz, Wolfgang ^b   Schölkens, Bernward A ^b   De Bold, Adolfo J ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b SANOFI   (France)

Author keywords

Angiotensinogen Na+K+ ATPase; Aorta; Atrial natriuretic factor; DOCA salt hypertension; Hypertrophy; PCR; Renal hypertension; Renin angiotensin system

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANGIOTENSINOGEN; ATRIAL NATRIURETIC FACTOR; DEOXYCORTICOSTERONE ACETATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MESSENGER RNA; RAMIPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA DISEASE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FEMALE; GENE EXPRESSION; HYPERTENSION; HYPERTROPHY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSINOGEN; ANIMALS; AORTA; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; BODY WEIGHT; DESOXYCORTICOSTERONE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HYPERTENSION; MALE; NA(+)-K(+)-EXCHANGING ATPASE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0031647273     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199812000-00019     Document Type: Article

References (30)

1. de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natnuretic response to intravenous injection of atrial myocardial extracts in rats. Life Sci 1981;28:89-94.
2. Flynn TG, de Bold ML, de Bold AJ. The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties. Biochem Biophys Res Commun 1983;117:859-65.
3. Hirsch AT, Creager MA, Dzau VJ. Relation of atrial natriuretic factor to vasoconstrictor hormones and regional blood flow in congestive heart failure. Am J Cardiol 1989;63:211-6.
4. Arjona AA, Hsu CA, Wrenn DS, Hill NS. Effects of natriuretic peptides on vascular smooth-muscle cells derived from different vascular beds. Gen Pharmacol 1997;28:387-92.
5. Akiho H, Chijiiwa Y, Okabe H, Harada N, Nawata H. Direct inhibitory effect of atrial natriuretic peptide on isolated caecal circular smooth muscle cells via soluble guanylate cyclase. Life Sci 1994;55:1293-9.
6. Gardner DG, Deschepper CF, Baxter JD. The gene for the atrial natriuretic factor is expressed in the aortic arch. Hypertension 1987;9:103-6.
7. Vesely DL, Palmer PA, Giordano AT. Atrial natriuretic factor prohormone peptides are present in a variety of tissues. Peptides 1992;13:165-70.
8. Ogawa T, Linz W, Stevenson M, et al. Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production. Circulation 1996;93:2059-67.
9. Orlowski J, Lingrel JB. Tissue-specific and developmental regulation of Rat Na,K-ATPase catalytic a isoform and β subunit mR-NAs. J Biol Chem 1988;263:10436-42.
10. +-ATPase a-subunit gene expression in hypertension. Science 1988;241:221-3.
11. 2 Na,K-ATPase gene expression in transgenic rats. Hypertension 1997;29:606-12.
12. Ogawa T, Bruneau BG, Yokota N, de Bold ML, de Bold AJ. Tissue-specific regulation of renal and cardiac atrial natriuretic factor gene expression in deoxycorticosterone acetate-salt rats. Hypertension 1997;30:1342-7.
13. 2-bradykinin receptor antagonist HOE 140 abolishes the antihypeitrophic effect of ramipril. Br J Pharmacol 1992;105:771-2.
14. Owens GK, Reidy MA. Hyperplastic growth response of vascular smooth muscle cells following induction of acute hypertension in rats by aortic coarctation. Circ Res 1995;57:695-705.
15. Lynch KR, Simnad VI, Ben-An ET, Garrison JC. Localization of preangiotensinogen messenger RNA sequences in the rat brain. Hypertension 1986;8:540-3.
16. Scholkens BA, Linz W, Martorana PA. Experimental cardiovascular benefits of angiotensin-converting enzyme inhibitors: beyond blood pressure reduction. J Cardiovasc Pharmacol 1991;18(suppl 2):S26-30.
17. Ikeda U, Takahashi M, Okada K, Saito T, Shirnada K. Regulation of Na-K-ATPase gene expression by angiotensin II in vascular smooth muscle cells. Am J Physiol 1994;267:H1295-302.
18. +-ATPase gene expression by corticosteroids in vascular smooth muscle cells. Am J Physiol 1996;270:C731-9.
19. Linz W, Schölkens BA, Ganten D. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exp Hypertens [A] 1989;1:1325-50.
20. Klett C, Hellmann W, Müller F, et al. Angiotensin II controls angiotensinogen secretion at a pretranslation level. J Hypertens 1988;6:S442-5.
21. Linz W, Schaper J, Wiemer G, Albus U, Schölkens BA. Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats. Br J Pharmacol 1992;107:970-5.
22. Oishi T, Ogura T, Yamauchi T, Harada K, Ota Z. Effect of renin-angiotensin inhibition on glomerular injuries in DOCA-salt hypertensive rats. Regul Pept 1996;62:89-95.
23. Komuro I, Kurihara H, Sugiyama T, Yoshizumi M, Takaku F, Yazaki Y. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells [published erratum appears in FEBS Lett 1989;244(2):509]. FEBS Lett 1988;238:249-52.
24. Unkelbach M, Auch-Schwelk W, Unkelbach E, Jautzke G, Fleck E. Regulation of aortic wall structure by the renin-angiotensin system in Wistar rats. J Cardiovasc Pharmacol 1998;31:31-8.
25. Yoshimoto T, Naruse M, Naruse K, et al. Gene expression of vascular natriuretic peptide receptor in the aorta of hypertensive rats. Clin Exp Pharmacol Physiol 1995;22(suppl 1):S175-6.
26. Komatsu Y, Itoh H, Suga S, et al. Regulation of endothelial production of C-type natriuretic peptide in coculture with vascular smooth muscle cells: role of the vascular natriuretic peptide system in vascular growth inhibition. Circ Res 1996;78:606-14.
27. Suga S, Nakao K, Kishimoto I, et al. Phenotype-related alteration in expression of natriuretic peptide receptors in aortic smooth muscle cells. Circ Res 1992;71:34-9.
28. Yokota N, Bruneau BG, Fernandez BE, et al. Dissociation of cardiac hypertrophy, myosin heavy chain isoform expression, and natriuretic peptide production in DOCA-salt rats. Am J Hypertens 1995;8:301-10.
29. Nazario B, Hu RM, Pedram A, Prins B, Levin ER. Atrial and brain natriuretic peptides stimulate the production and secretion of C-type natriuretic peptide from bovine aortic endothelial cells J Clin Invest 1995;95:1151-7.
30. Yoshimoto T, Naruse M, Tanabe A, et al. Angiotensin converting enzyme inhibitor but not calcium blocker down-regulates gene expression of vascular natriuretic peptide receptor in hypertensive rats. Biochem Biophys Res Commun 1994;205: 1595-600.